ABSTRACT
To provide a better service for senior health care, we summarized screening studies of traditional Chinese anti-aging materia medica (TCAM). We collected and analyzed literature of TCAM screening studies using the lifespan test and animal models of aging from 1984 to 2012. We found 26 screening methods for TCAM, and 153 single herbs or active ingredients of TCAM that have been screened out during the past 28 years. The cell lifespan test, the fruit fly lifespan test, and D-galactose aging model were the most widely used and intensively studied screening methods. However, the method for establishing the D-galactose aging model needs to be standardized, and the D-galactose aging model cannot completely be a substitute for the normal aging mouse model. Great success has been achieved in screening studies in TCAM. To further improve screening studies in TCAM, we suggest that the D-galactose aging model be incorporated into the lifespan test in the New Drugs of Traditional Chinese Medicine Research Guide.
Subject(s)
Animals , Humans , Aging , Drug Evaluation, Preclinical , Drugs, Chinese Herbal , Pharmacology , Materia Medica , Pharmacology , Medicine, Chinese Traditional , Models, AnimalABSTRACT
This study is to optimize the preparation process of fusion protein Fv-LDP which was expressed in the form of inclusion body and consisted of lidamycin apoprotein LDP and single-chain Fv antibody (scFv) directed against type IV collagenase. The preparation and the dissolution of inclusion body, the immobilized metal affinity chromatography of the target protein and the renaturization by stepwise dialysis were optimized by single-factor analysis or orthogonal design. In addition, the refolded fusion protein Fv-LDP was refined by Sephadex G-75 chromatography followed by fluorescence-activated cell sorter (FACS)-based saturation binding assay to measure its antigen-binding activity. After optimization of the process, the purity of fusion protein Fv-LDP existed in the inclusion body was 63.9% and the corresponding solubility was 95.7%; Under denaturing conditions, the purity of fusion protein Fv-LDP was more than 95% after the purification process. The percentage of monomeric fusion protein Fv-LDP was 60% after the refolding process, while it was further refined to 85% which was 5.6-fold higher than that of the initial refolding condition. The refined fusion protein Fv-LDP could bind to human lung adenocarcinoma PAa cells and human hepatoma BEL-7402 cells with the dissociation constants (Kd) of 0.176 micromol x L(-1) and 0.904 micromol x L(-1), respectively. The preparation process of fusion protein Fv-LDP has been successfully optimized, which provides the experimental basis for the production and future development of fusion protein Fv-LDP, and might serve as a relatively practical system for the preparation of other scFv-based proteins expressed in the form of inclusion body.
Subject(s)
Humans , Adenocarcinoma , Metabolism , Pathology , Aminoglycosides , Chemistry , Metabolism , Antibiotics, Antineoplastic , Chemistry , Metabolism , Apoproteins , Chemistry , Metabolism , Carcinoma, Hepatocellular , Metabolism , Pathology , Cell Line, Tumor , Collagenases , Allergy and Immunology , Enediynes , Chemistry , Metabolism , Escherichia coli , Chemistry , Metabolism , Inclusion Bodies , Chemistry , Metabolism , Liver Neoplasms , Metabolism , Pathology , Lung Neoplasms , Metabolism , Pathology , Protein Binding , Recombinant Fusion Proteins , Chemistry , Metabolism , Single-Chain Antibodies , Chemistry , MetabolismABSTRACT
LPS stimulation of macrophages production of IFN-beta plays a key role in innate immunity defending the microbial invasion. In this study, the effect of S632A3 promoting LPS-induced IFN-beta production and the underlying mechanism were investigated, mRNA level was measured by real-time PCR, cytokine production was determined by ELISA, GSK-3beta activity was investigated by kinase assay, protein phosphorylation and expression were evaluated by Western blotting. The results revealed that S632A3 significantly augmented IFN-beta production by LPS-stimulated macrophages. S632A3 inhibition of the activation of GSK-3beta, reduced the threonine 239 phosphorylation of transcription factor c-Jun but increased the total level of c-Jun in LPS-stimulated macrophages. Moreover, small interfering RNA-mediated knockdown of c-Jun level abrogated the ability of S632A3 to augment IFN-beta. The study thus demonstrates S632A3 being a new anti-inflammation lead compound and provides a molecular mechanism by which S632A3 promoted LPS-induced IFN-beta production in macrophages through inhibiting the activation of GSK-3beta.
Subject(s)
Animals , Mice , Anti-Bacterial Agents , Pharmacology , Cell Line , Enzyme Activation , Glycogen Synthase Kinase 3 , Metabolism , Glycogen Synthase Kinase 3 beta , Interferon-beta , Genetics , Lipopolysaccharides , Pharmacology , Macrophages , Cell Biology , Metabolism , Phosphorylation , Piperidones , Pharmacology , Proto-Oncogene Proteins c-jun , Metabolism , RNA, Messenger , Metabolism , RNA, Small Interfering , Genetics , TransfectionABSTRACT
<p><b>OBJECTIVE</b>To investigate the protective effects of putative AGEs (advanced glycation endproducts) inhibitor salidroside against aging in an accelerated mouse aging model induced by D-galactose.</p><p><b>METHODS</b>A group of 5-month-old C57BL/6J mice were treated daily with D-galactose, D-galactose combined with salidroside, salidroside alone, and control buffer for 8 weeks. At the end of the treatment, serum AGEs levels, neurological activities, expression of glial fibrillary acidic protein (GFAP) and neurotrophin-3 (NT-3) in the cerebral cortex, as well as lymphocyte proliferation and IL-2 production were determined.</p><p><b>RESULTS</b>D-galactose induced mouse aging model was developed as described before. As expected, salidroside blocked D-galactose induced increase of serum AGEs levels. It also reversed D-galactose induced aging effects in neural and immune system, as evidenced by improving motor activity, increasing memory latency time, and enhancing lymphocyte mitogenesis and interleukin-2 (IL-2) production. Furthermore, elevated expression of GFAP and NT-3 in the aged model mice was also reduced upon salidroside treatment.</p><p><b>CONCLUSION</b>Salidroside inhibits AGEs formation in vivo, which at least partially contributes to its anti-aging effect in D-galactose induced aging model.</p>
Subject(s)
Animals , Mice , Aging, Premature , Blood , Cerebral Cortex , Metabolism , Drugs, Chinese Herbal , Pharmacology , Therapeutic Uses , Galactose , Glial Fibrillary Acidic Protein , Glucosides , Pharmacology , Therapeutic Uses , Glycation End Products, Advanced , Blood , Interleukin-2 , Metabolism , Memory , Mice, Inbred C57BL , Motor Activity , Nerve Growth Factors , Metabolism , Nerve Tissue Proteins , Metabolism , Phenols , Pharmacology , Therapeutic Uses , Spleen , Allergy and Immunology , T-LymphocytesABSTRACT
<p><b>OBJECTIVE</b>Lidamycin, an enediyne antibiotic, leads to apoptosis and mitotic cell death of human tumor cells at high and low concentrations. The reason why tumor cells have distinct responses to lidamycin remains elusive. This study was to elucidate if cellular prosurvival molecules are involved in these responses.</p><p><b>METHODS</b>Cleavage of chromatin and DNA was observed by chromatin condensation and agarose gel electrophoresis. Accumulation of rhodamine 123 in lidamycin-treated cells was assayed by flow cytometry. Cell multinucleation was detected by staining with Hoechst 33342. Western blot and senescence-associated beta-galactosidase (SA-beta-gal) staining were used to analyze protein expression and senescence-like phenotype, respectively.</p><p><b>RESULTS</b>SIRT1 deacetylase remained unchanged in 0.5 nmol/L lidamycin whereas cleavage occurred when apoptosis was induced by lidamycin. Increased FOXO3a, SOD-1 and SOD-2 expression and transient phosphorylation of ERK were detected after exposure of human hepatoma BEL-7402 cells to 0.5 nmol/L lidamycin. High expressions of SIRT1 and Akt were found in colon carcinoma HCT116 p53 knock-out cells exposed to lidamycin. Degradation of PARP and p53 by lidamycin as a substitute for SIRT1 and Akt was confirmed with caspase inhibitor Q-VD-OPh and proteasome inhibitor MG132. Resistance to lidamycin-induced DNA cleavage was observed in breast cancer doxorubicin-resistant MCF-7 cells. This was not induced by P-glycoprotein as no accumulation of rhodamine 123 was detected in the resistant cells following exposure to lidamycin. In contrast to sensitive MCF-7 cells, a lower multinucleation rate for the resistant cells was measured following exposure to equal concentrations of lidamycin.</p><p><b>CONCLUSIONS</b>Cellular prosurvival molecules, such as SIRT1, Akt, SOD-1, SOD-2 and other unknown factors can influence the action of lidamycin on human tumor cells.</p>
Subject(s)
Humans , Aminoglycosides , Pharmacology , Antibiotics, Antineoplastic , Pharmacology , Cell Death , Cell Line, Tumor , DNA Cleavage , Doxorubicin , Pharmacology , Enediynes , Pharmacology , Forkhead Box Protein O3 , Forkhead Transcription Factors , Genetics , Metabolism , Gene Expression Regulation , Mitogen-Activated Protein Kinase Kinases , Genetics , Metabolism , Poly(ADP-ribose) Polymerases , Genetics , Metabolism , Proto-Oncogene Proteins c-akt , Genetics , Metabolism , Signal Transduction , Sirtuin 1 , Sirtuins , Genetics , Metabolism , Tumor Suppressor Protein p53 , Genetics , MetabolismABSTRACT
<p><b>OBJECTIVE</b>To study whether Lycium barbarum glycopeptide 3 (LBGP3) affects T cell apoptosis in aged mice.</p><p><b>METHODS</b>LBGP3 was purified with DEAE cellulose and Sephadex columns. Apoptotic "sub-G1 peak" was detected by flow cytometry and DNA ladder was resolved by agarose gel electrophoresis. Levels of IFN-gamma and IL-10 were measured with specific kits and mRNA expression was detected by RT-PCR. Apoptosis-related proteins of FLIP, FasL, and Bcl-2 were determined by Western blotting.</p><p><b>RESULTS</b>LBGP3 was purified from Fructus Lycii water extracts and identified as a 41 kD glycopeptide. Treatment with 200 microg/mL LBGP3 increased the apoptotic rate of T cells from aged mice and showed a similar DNA ladder pattern to that in young T cells. The reversal of apoptotic resistance was involved in down-regulating the expression of Bcl-2 and FLIP, and up-regulating the expression of FasL.</p><p><b>CONCLUSION</b>Lycium barbarum glycopeptide 3 reverses apoptotic resistance of aged T cells by modulating the expression of apoptosis-related molecules.</p>
Subject(s)
Animals , Mice , Aging , Allergy and Immunology , Apoptosis , Fas Ligand Protein , Allergy and Immunology , Glycopeptides , Pharmacology , Interferon-gamma , Genetics , Allergy and Immunology , Interleukin-10 , Genetics , Allergy and Immunology , Lycium , Chemistry , Mice, Inbred C57BL , Proto-Oncogene Proteins c-bcl-2 , Allergy and Immunology , RNA, Messenger , Allergy and Immunology , T-Lymphocytes , Allergy and ImmunologyABSTRACT
The mechanism of apoptosis induced by SIRT1 deacetylase inhibitors in both human breast cancer MCF-7 and MCF-7 doxorubicin-resistant cells was studied. MTT assay was used to detect growth-inhibitory effect on the cells. Protein expression was detected by Western blotting. Chromatin condensation was detected by a fluorescent microscope after Hoechst 33342 staining. Cell cycle distribution was analyzed with flow cytometry. Apoptotic cells were detected with Annexin V staining. Nicotinamide (NAM) and Sirtinol, two SIRT1 deacetylase inhibitors, exhibited the similar growth-inhibitory effects on MCF-7/DOX cells and MCF-7 cells, but no potentiation of DOX activities. The arrest at G2/M phase was detected by flow cytometry in both MCF-7 and MCF-7/DOX cells after NAM treatment. Activation of caspase pathway in MCF-7 cells, such as the cleavages of PARP, caspase-6, -7, -9, were observed after exposure to NAM 50 mmol x L(-1), accompanied by the occurrence of chromatin condensation and Annexin V positive cells. However, the cleavages of PARP, caspase-6 and -7 in MCF-7/DOX cells delayed after exposure to NAM for 24 h and obviously increased at 48 h with appearance of chromatin condensation and Annexin V positive cells. SIRT1 deacetylase inhibitors show no cross resistance to MCF-7 drug-resistant cells, and the similar growth-inhibitory actions of them to MCF-7 sensitive and drug-resistant cells by which it is mediated by activation of apoptotic caspase pathway.
Subject(s)
Female , Humans , Apoptosis , Benzamides , Pharmacology , Breast Neoplasms , Metabolism , Pathology , Caspases , Metabolism , Cell Cycle , Cell Line, Tumor , Cell Proliferation , Doxorubicin , Pharmacology , Drug Resistance, Multiple , Drug Resistance, Neoplasm , Enzyme Inhibitors , Pharmacology , Naphthols , Pharmacology , Niacinamide , Pharmacology , Sirtuin 1ABSTRACT
Although enediyne antibiotic lidamycin ( LDM) is a potent inducer of apoptosis, the underlying mechanisms of its apoptotic functions remain to be explored. Here, we aim to elucidate its possible mechanisms in mitochondria initiated apoptotic pathway involved in human BEL-7402 and MCF-7 cells. Cytochrome c released from mitchondria to cytosol fraction was detected by Western blotting. p53 and Bax, Bcl-2 expressions were detected by Western blotting and RT-PCR. MTT assay was used to detect cytotoxicity of LDM with or without caspase inhibitor z-VAD-fmk. After the BEL-7402 cells were exposed to 0. 1 micromol x L(-1) LDM within 6 h, the increase of cytochrome c in the cytosol and decrease in the mitochondria were observed when compared with untreated cells. The expression of Bax, an important proapoptotic member of the Bcl-2 family, increased gradually in the BEL-7402 cells after exposure to LDM of 0. 1 micromol x L (-1) for 2, 6, and 9 h, separately, while Bcl-2 increased at 2 and 6 h, and decreased at 9 h after LDM treatment. Enhanced protein expressions were parallel with respective increased mRNA level for Bax only, but not p53. Caspase inhibitor may inhibit partially the killing effects induced by LDM. Therefore we conclude that the rapid activation of mitochondrial pathway induced by LDM in tumor cells might contribute to its highly potent cytotoxicities.
Subject(s)
Humans , Amino Acid Chloromethyl Ketones , Pharmacology , Aminoglycosides , Pharmacology , Antibiotics, Antineoplastic , Pharmacology , Apoptosis , Blotting, Western , Caspase Inhibitors , Caspases , Metabolism , Cell Line, Tumor , Cytochromes c , Metabolism , Cytosol , Metabolism , Enediynes , Pharmacology , Membrane Potential, Mitochondrial , Mitochondria , Metabolism , Proto-Oncogene Proteins c-bcl-2 , Genetics , RNA, Messenger , Genetics , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Tumor Suppressor Protein p53 , Genetics , bcl-2-Associated X Protein , GeneticsABSTRACT
<p><b>OBJECTIVE</b>To investigate the effect of lidamycin (LDM) on telomerase activity in human hepatoma BEL-7402 cells under the condition of LDM inducing mitotic cell death and senescence.</p><p><b>METHODS</b>Chromatin condensation was detected by co-staining with Hoechst 33342 and PI. Cell multinucleation was observed by Giemsa staining and genomic DNA was separated by agarose gel electrophoresis. Fluorescent intensity of Rho123 was determined for mitochondrial membrane potential. MTT assay and SA-beta-gal staining were employed to analyze the senescence-like phenotype. The expression of proteins was analyzed by Western blot. Telomerase activity was assayed by telomerase PCR-ELISA.</p><p><b>RESULTS</b>Mitotic cell death occurred in LDM-treated cells characterized by unique and atypical chromatin condensation, multinucleation and increased mitochondrial membrane potential. However, no apoptotic bodies or DNA ladders were found. In addition, apoptosis-related proteins remained nearly unaltered. Senescence-like phenotype was identified by increased and elongated size of cells, growth retardation, enhanced SA-beta-gal activity and the changes of senescence-related protein expression. Telomerase activity markedly decreased (P<0.01) in LDM-treated hepatoma BEL-7402 cells.</p><p><b>CONCLUSION</b>Mitotic cell death and senescence could be triggered simultaneously or sequentially after exposure of hepatoma BEL-7402 cells to LDM. The decrease in telomerase activity may play a key role in the defective mitosis and aging morphology. Further investigation of detailed mechanism is needed.</p>
Subject(s)
Humans , Aminoglycosides , Pharmacology , Antibiotics, Antineoplastic , Pharmacology , Apoptosis , Azure Stains , Benzimidazoles , Carcinoma, Hepatocellular , Pathology , Cell Nucleus , Metabolism , Cellular Senescence , Chromatin , Metabolism , DNA, Neoplasm , Dose-Response Relationship, Drug , Enediynes , Pharmacology , Genome, Human , Genetics , Liver Neoplasms , Pathology , Membrane Potential, Mitochondrial , Mitosis , Phenotype , Propidium , Telomerase , Metabolism , Time Factors , beta-Galactosidase , MetabolismABSTRACT
<p><b>OBJECTIVE</b>To investigate the role of D-galactose, especially in the structural and functional changes of the immune system in aging.</p><p><b>METHODS</b>Serum levels of advanced glycation end-products (AGE) were determined by ELISA method. Ultra-structures of thymus and spleen were detected by transmission electron microscopy. MTT method was used to determine the lymphocyte proliferation. IL-2 activity was determined by bioassay. Northern blot was used to detect the IL-2 mRNA levels.</p><p><b>RESULTS</b>Serum AGE levels of D-galactose- (P < 0.01) and AGE-treated (P < 0.05) mice (n = 8) were increased significantly. The ultra-structures of thymus and spleen in D-galactose- and AGE-treated mice showed regressive changes similar to those in the aged control group. The lymphocyte mitogenesis and IL-2 activity of spleen were also decreased significantly (P < 0.01, n = 8). The change of IL-2 activity shown by Northern blot resulted from the change of mRNA expression. The AGE plus aminoguanidine group, however, showed no significant change in these parameters in comparison with the young control group (P < 0.01 or P < 0.05, n = 8).</p><p><b>CONCLUSION</b>D-galactose and AGE lead to a mimic regression change of aging in the immune system in vivo.</p>
Subject(s)
Animals , Mice , Aging , Allergy and Immunology , Cell Proliferation , Galactose , Pharmacology , Glycation End Products, Advanced , Blood , Interleukin-2 , Metabolism , Lymphocytes , Allergy and Immunology , Microscopy, Electron, Transmission , RNA, Messenger , Metabolism , Spleen , Allergy and Immunology , Thymus Gland , Allergy and ImmunologyABSTRACT
<p><b>OBJECTIVE</b>To investigate whether two kinds of in vitro prepared advanced glycation end products (AGEs), Glu-BSA and Gal-BSA, could change oxidation stress and anti-oxidation abilities in astrocytes, and thus might contribute to brain injury.</p><p><b>METHODS</b>Changes of GSH, MDA, SOD, MAO-B, nitric oxide were measured after AGEs treatment.</p><p><b>RESULTS</b>Both 0.1 g/L Glu-BSA and Gal-BSA could slightly decrease GSH level, while 1 g/L of them significantly decreased GSH level by 35% and 43% respectively. The MDA levels of both 1 g/L AGEs treated groups (306 +/- 13 and 346 +/- 22) were higher than that of the normal group (189 +/- 18), which could be inhibited by free radical scavenger NAC. The SOD activities of both 1 g/L AGEs treated groups (67.0 +/- 5.2 and 74.0 +/- 11.0) were lower than that of the normal group (85.2 +/- 8.0). Both 0.1 g/L AGEs could slightly increase the activity of MAO-B, while 1 g/L of them could increase MAO-B activity by 1.5 and 1.7 folds respectively. Both AGEs stimulation could produce NO level by 1.7 and 2 folds respectively.</p><p><b>CONCLUSION</b>Enhanced levels of astrocytic oxidation stress and decrease of antioxidation abilities may contribute to, at least partially, the detrimental effects of AGEs in neuronal disorders and aging brain.</p>
Subject(s)
Animals , Cattle , Rats , Astrocytes , Metabolism , Cells, Cultured , Cerebral Cortex , Cell Biology , Glutathione , Metabolism , Glycation End Products, Advanced , Pharmacology , Malondialdehyde , Metabolism , Monoamine Oxidase , Metabolism , Nitric Oxide , Metabolism , Oxidative Stress , Rats, Wistar , Serum Albumin, Bovine , Pharmacology , Superoxide Dismutase , MetabolismABSTRACT
<p><b>OBJECTIVE</b>To analyze the effects of aging or advanced glycation on gene expression in the cerebrum and spleen of female C57BL/6J mice.</p><p><b>METHODS</b>The gene expression profile was determined by using cDNA expression arrays containing 588 cDNA.</p><p><b>RESULTS</b>Aging and advanced glycation resulted in differential gene expression patterns of cerebrum and spleen compared with young mice. Among the 80 genes detected in cerebrum, 43 exhibited a change in mRNA ratios with aging or treatment. Thirty-four changes (79%) were common in aged and D-galactose treated mice, whereas the cerebrum from aged and AGE-lysine treated mice showed common changes in expression of 38 genes (88%). Of the 86 genes detected in spleen, 29 (34%) displayed an age-related decrease in expression, whereas 3 (3%) displayed an increase in expression levels with aging. Eighteen genes from the detectable genes exhibited expression changes in both cerebrum and spleen of mice.</p><p><b>CONCLUSIONS</b>The gene expression profiles of D-galactose and AGE-lysine treated mice resemble those of aged mice. Use of cDNA hybridization arrays may provide a promising tool to explore the mechanism of aging at a molecular level.</p>
Subject(s)
Animals , Female , Mice , Aging , Physiology , Gene Expression Regulation , Glucose , Metabolism , Mice, Inbred C57BL , Oligonucleotide Array Sequence Analysis , Spleen , Physiology , Telencephalon , PhysiologyABSTRACT
<p><b>OBJECTIVE</b>To investigate the inhibiting effects and mechanism of achyranthes bidentata polysaccharide (ABP) and lycium barbarum polysaccharide (LBP) on nonenzyme glycation in D-galactose induced mouse aging model.</p><p><b>METHODS</b>Serum AGE levels were determined by AGE-ELISA, MTT method was used to determine lymphocyte proliferation, IL-2 activity was determined by a bioassay method. Spontaneous motor activity was used to detect mouse's neuromuscular movement, latency of step-through method was used to examine learning and memory abilities of mouse, colormetric assay was used to determine hydroxyproline concentration in mouse skin, pyrogallol autoxidation method was used to determine superoxide dismutase (SOD) activity of erythrocytes.</p><p><b>RESULTS</b>Decreased levels of serum AGE, hydroxyproline concentration in mouse skin and spontaneous motor activity in D-galactose mouse aging model were detected after treated with ABP or LBP, while lymphocyte proliferation and IL-2 activity, learning and memory abilities, SOD activity of erythrocytes, were enhanced.</p><p><b>CONCLUSIONS</b>ABP and LBP could inhibit nonenzyme glycation in D-galactose induced mouse aging model in vivo and ABP has a better inhibiting effect than LBP.</p>
Subject(s)
Animals , Female , Mice , Achyranthes , Chemistry , Aging , Physiology , Disease Models, Animal , Erythrocytes , Galactose , Chemistry , Learning , Lycium , Chemistry , Memory , Mice, Inbred C57BL , Motor Activity , Polysaccharides , Pharmacology , Superoxide Dismutase , PharmacologyABSTRACT
<p><b>AIM</b>To investigate the synergetic effect and the mechanism of antitumor action of the antibiotic lidamycin in combination with cisplatin in vitro.</p><p><b>METHODS</b>Cytotoxicity of the drugs was measured by clonogenic assay. Chromatin condensation was observed by co-staining with fluorescent dyes, Hoechst 33342 and propidium iodide. Apoptotic sub-G1 was detected by flow cytometry and DNA ladder was observed using agarose gel electrophoresis. Bcl-2 protein level was detected by Western blot assay.</p><p><b>RESULTS</b>By using clonogenic assay, lidamycin in combination with cisplatin was found to have synergetic effects on the proliferation of human hepatoma BEL-7402 cells. The data showed that BEL-7402 cells treated with cisplatin and lidamycin in combination produced internucleosomal DNA fragmentation analysed by agarose gel electrophoresis. The results of flow cytometry showed that cisplatin and lidamycin administrated in combination showed no obvious change in G1 phase distribution compared with single treatment. However, this combination reduced the S phase arrest and reversed the reduction of G2/M phase induced by single treatment. The results also showed that there was 11.3% or 9.37% of cells undergoing apoptosis in BEL-7402 cells treated with cisplatin or lidamycin, respectively, while it showed 32.4% of apoptotic cells in combination treatment. Cisplatin, lidamycin and combination of cisplatin and lidamycin was shown to induce typical chromatin condensation in BEL-7402 cells. The study showed that 0.5 mumol.L-1 cisplatin or 1 x 10(-4) mumol.L-1 lidamycin alone decreased Bcl-2 protein level, while lidamycin in combination with cisplatin strongly inhibited expression of Bcl-2 proteins in BEL-7402 cells.</p><p><b>CONCLUSION</b>The results suggest that lidamycin enhancement of cisplatin-induced apoptosis associates with decrease of Bcl-2 protein expression, which may be useful for cancer chemotherapy.</p>
Subject(s)
Humans , Aminoglycosides , Pharmacology , Antibiotics, Antineoplastic , Pharmacology , Antineoplastic Agents , Pharmacology , Apoptosis , Carcinoma, Hepatocellular , Pathology , Cisplatin , Pharmacology , Drug Synergism , Enediynes , Liver Neoplasms , Metabolism , Pathology , Proto-Oncogene Proteins c-bcl-2 , Metabolism , S Phase , Tumor Cells, CulturedABSTRACT
<p><b>OBJECTIVE</b>To explore the effect of Dogwood fruits on tonifying kidney-yang.</p><p><b>METHOD</b>The effect of the water extract of Dogwood fruits on rats model of kidney-yang deficiency with the hydrocortisone was observed.</p><p><b>RESULT</b>The water extract of Dogwood fruits could make normal the liver weight, and mitigate hepatocyte pathologic changes, increase the heptocellular levels of RNA and hepatin, and decrease the malondialdehyde (MDA) in rats model of kidney-yang deficiency. It could also make the viscera quotiety return to normal way and increase the levels of RNA in the interstitial cells of testicle in rats model of kidney-yang deficiency.</p><p><b>CONCLUSION</b>Water extract of Dogwood fruits can protect and improve the functions of the liver and testicle in rats model of kidney-yang deficiency.</p>